Literature DB >> 21618162

Increased average longevity among the "Tour de France" cyclists.

F Sanchis-Gomar1, G Olaso-Gonzalez, D Corella, M C Gomez-Cabrera, J Vina.   

Abstract

It is widely held among the general population and even among health professionals that moderate exercise is a healthy practice but long term high intensity exercise is not. The specific amount of physical activity necessary for good health remains unclear. To date, longevity studies of elite athletes have been relatively sparse and the results are somewhat conflicting. The Tour de France is among the most gruelling sport events in the world, during which highly trained professional cyclists undertake high intensity exercise for a full 3 weeks. Consequently we set out to determine the longevity of the participants in the Tour de France, compared with that of the general population. We studied the longevity of 834 cyclists from France (n=465), Italy (n=196) and Belgium (n=173) who rode the Tour de France between the years 1930 and 1964. Dates of birth and death of the cyclists were obtained on December 31 (st) 2007. We calculated the percentage of survivors for each age and compared them with the values for the pooled general population of France, Italy and Belgium for the appropriate age cohorts. We found a very significant increase in average longevity (17%) of the cyclists when compared with the general population. The age at which 50% of the general population died was 73.5 vs. 81.5 years in Tour de France participants. Our major finding is that repeated very intense exercise prolongs life span in well trained practitioners. Our findings underpin the importance of exercising without the fear that becoming exhausted might be bad for one's health. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21618162     DOI: 10.1055/s-0031-1271711

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  18 in total

Review 1.  Exercise: the lifelong supplement for healthy ageing and slowing down the onset of frailty.

Authors:  Jose Viña; Leocadio Rodriguez-Mañas; Andrea Salvador-Pascual; Francisco José Tarazona-Santabalbina; Mari Carmen Gomez-Cabrera
Journal:  J Physiol       Date:  2016-04-15       Impact factor: 5.182

2.  Rebuttal from Jonatan R. Ruiz, Michael Joyner and Alejandro Lucia.

Authors:  Jonatan R Ruiz; Michael Joyner; Alejandro Lucia
Journal:  J Physiol       Date:  2013-10-15       Impact factor: 5.182

Review 3.  Competitive sports and the heart: benefit or risk?

Authors:  Jürgen Scharhag; Herbert Löllgen; Wilfried Kindermann
Journal:  Dtsch Arztebl Int       Date:  2013-01-07       Impact factor: 5.594

4.  Do olympic athletes train as in the Paleolithic era?

Authors:  Daniel A Boullosa; Laurinda Abreu; Adrián Varela-Sanz; Iñigo Mujika
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

Review 5.  Exercise acts as a drug; the pharmacological benefits of exercise.

Authors:  J Vina; F Sanchis-Gomar; V Martinez-Bello; M C Gomez-Cabrera
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 6.  Arrhythmogenesis of Sports: Myth or Reality?

Authors:  Saad Fyyaz; Michael Papadakis
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

7.  Does physical activity increase life expectancy? A review of the literature.

Authors:  C D Reimers; G Knapp; A K Reimers
Journal:  J Aging Res       Date:  2012-07-01

8.  Serum copeptin and midregion proadrenomedullin (MR-proADM) after an ultramarathon.

Authors:  Giuseppe Lippi; Federico Schena; Gian Luca Salvagno; Fabian Sanchis-Gomar; Gian Cesare Guidi
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

9.  Longer leukocyte telomeres are associated with ultra-endurance exercise independent of cardiovascular risk factors.

Authors:  Joshua Denham; Christopher P Nelson; Brendan J O'Brien; Scott A Nankervis; Matthew Denniff; Jack T Harvey; Francine Z Marques; Veryan Codd; Ewa Zukowska-Szczechowska; Nilesh J Samani; Maciej Tomaszewski; Fadi J Charchar
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

Review 10.  Do Elite Athletes Live Longer? A Systematic Review of Mortality and Longevity in Elite Athletes.

Authors:  Srdjan Lemez; Joseph Baker
Journal:  Sports Med Open       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.